Acrospire Investment Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-6,956
| Closed | -$77K | – | 2021 |
|
|
2017
Q2 | $77K | Buy |
6,956
+1,320
| +23% | +$14.6K | 0.07% | 443 |
|
|
2017
Q1 | $55K | Sell |
5,636
-7,994
| -59% | -$78K | 0.05% | 863 |
|
|
2016
Q4 | $147K | Buy |
13,630
+848
| +7% | +$9.15K | 0.06% | 629 |
|
|
2016
Q3 | $131K | Buy |
12,782
+8,375
| +190% | +$85.8K | 0.09% | 352 |
|
|
2016
Q2 | $58K | Sell |
4,407
-4,953
| -53% | -$65.2K | 0.04% | 948 |
|
|
2016
Q1 | $103K | Buy |
+9,360
| New | +$103K | 0.07% | 311 |
|